Flagship Ventures Fund V General Partner Llc Sigilon Therapeutics, Inc. (SGTX) insider trading activity

SGTX Quotes by TradingView

Flagship Ventures Fund V General Partner LLC Transaction History

Date Transaction Value Shares Traded Form
Aug 11 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$11,901,982 $14.92 p/Share
797,720
Dec 08 2020
BUY
Conversion of derivative security
-
10,370,369

Also insider at

SANA
Sana Biotechnology, Inc. Healthcare
> 10% Shareholder
FHTX
Foghorn Therapeutics Inc. Healthcare
> 10% Shareholder
EVLO
Evelo Biosciences, Inc. Healthcare
> 10% Shareholder
CDAK
Codiak BioSciences, Inc. Healthcare
> 10% Shareholder
KLDO
Kaleido Biosciences, Inc. Healthcare
Director
FVF

Flagship Ventures Fund V General Partner LLC

> 10% Shareholder
Cambridge, MA

Track Institutional and Insider Activities on SGTX

Follow Sigilon Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGTX shares.

Notify only if

Insider Trading

Get notified when an Sigilon Therapeutics, Inc. insider buys or sells SGTX shares.

Notify only if

News

Receive news related to Sigilon Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SGTX